BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33745529)

  • 1. Iatrogenic Vitreous Hemorrhage, Subretinal Hemorrhage, and Branch Retinal Vein Occlusion after YAG Laser Vitreolysis for Symptomatic Vitreous Floaters.
    Shields RA; Cheng OT; Wolfe JD
    Ophthalmology; 2021 Apr; 128(4):616. PubMed ID: 33745529
    [No Abstract]   [Full Text] [Related]  

  • 2. Iatrogenic retinal damage and vitreous hemorrhage secondary to YAG laser.
    Pinto AM; Mishra AV; Gupta RR
    Can J Ophthalmol; 2023 Jun; 58(3):e118-e119. PubMed ID: 36057340
    [No Abstract]   [Full Text] [Related]  

  • 3. Retinal Complications after Yttrium-Aluminum-Garnet Laser Vitreolysis for Vitreous Floaters.
    Shields RA; Cheng OT; Ruby AJ; Williams GA; Wolfe JD
    Ophthalmic Surg Lasers Imaging Retina; 2021 Nov; 52(11):610-613. PubMed ID: 34766848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel OCT Application and Optimized YAG Laser Enable Visualization and Treatment of Mid- to Posterior Vitreous Floaters.
    Singh IP
    Ophthalmic Surg Lasers Imaging Retina; 2018 Oct; 49(10):806-811. PubMed ID: 30395668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute retinal detachment after Nd:YAG treatment for vitreous floaters and postertior capsule opacification: a case report.
    Liu X; Wang Q; Zhao J
    BMC Ophthalmol; 2020 Apr; 20(1):157. PubMed ID: 32306922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of yttrium-aluminium garnet (YAG) laser vitreolysis for vitreous floaters.
    Luo J; An X; Kuang Y
    J Int Med Res; 2018 Nov; 46(11):4465-4471. PubMed ID: 30200800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YAG Laser Vitreolysis vs Sham YAG Vitreolysis for Symptomatic Vitreous Floaters: A Randomized Clinical Trial.
    Shah CP; Heier JS
    JAMA Ophthalmol; 2017 Sep; 135(9):918-923. PubMed ID: 28727887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral posterior capsule injury after Nd:YAG laser vitreolysis: unintended consequence of floaters treatment.
    O'Day R; Cugley D; Chen C; Fabinyi D
    Clin Exp Ophthalmol; 2018 Nov; 46(8):956-958. PubMed ID: 29573082
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and Efficacy of YAG Laser Vitreolysis for the Treatment of Vitreous Floaters: An Overview.
    Katsanos A; Tsaldari N; Gorgoli K; Lalos F; Stefaniotou M; Asproudis I
    Adv Ther; 2020 Apr; 37(4):1319-1327. PubMed ID: 32086749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laser treatment of premacular haemorrhage.
    Krohn J; Kjersem B
    Tidsskr Nor Laegeforen; 2013 Jan; 133(1):41. PubMed ID: 23306992
    [No Abstract]   [Full Text] [Related]  

  • 11. Modern vitreolysis-YAG laser treatment now a real solution for the treatment of symptomatic floaters.
    Singh IP
    Surv Ophthalmol; 2020; 65(5):581-588. PubMed ID: 32135174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nd:YAG vitreolysis and pars plana vitrectomy: surgical treatment for vitreous floaters.
    Delaney YM; Oyinloye A; Benjamin L
    Eye (Lond); 2002 Jan; 16(1):21-6. PubMed ID: 11913884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laser vitreolysis for symptomatic floaters is not yet ready for widespread adoption.
    Su D; Shah CP; Hsu J
    Surv Ophthalmol; 2020; 65(5):589-591. PubMed ID: 32135173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Vitreous Structure and Visual Function after Neodymium:Yttrium-Aluminum-Garnet Laser Vitreolysis.
    Nguyen JH; Nguyen-Cuu J; Yu F; Yee KM; Mamou J; Silverman RH; Ketterling J; Sebag J
    Ophthalmology; 2019 Nov; 126(11):1517-1526. PubMed ID: 31471088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cataracts induced by neodymium-yttrium-aluminium-garnet laser lysis of vitreous floaters.
    Koo EH; Haddock LJ; Bhardwaj N; Fortun JA
    Br J Ophthalmol; 2017 Jun; 101(6):709-711. PubMed ID: 27574177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of YAG-laser vitreolysis effectiveness based on quantitative characterization of vitreous floaters].
    Shaimova VA; Shaimov TB; Shaimov RB; Galin AY; Goloshchapova ZA; Ryzhkov PK; Fomin AV
    Vestn Oftalmol; 2018; 134(1):56-62. PubMed ID: 29543200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To Treat or Not to Treat: Management Options for Symptomatic Vitreous Floaters.
    Broadhead GK; Hong T; Chang AA
    Asia Pac J Ophthalmol (Phila); 2020; 9(2):96-103. PubMed ID: 32097127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Swept source optical coherence tomography in globe perforation.
    Dubey D; Shanmugam M; Ramanjulu R; Mishra KCD; Doshi B
    Indian J Ophthalmol; 2019 Oct; 67(10):1697-1698. PubMed ID: 31546515
    [No Abstract]   [Full Text] [Related]  

  • 19. LASER VITREOLYSIS IN PATIENTS WITH SYMPTOMATIC VITREOUS FLOATERS.
    Janeková A; Veith M; Fillová D; Janek M
    Cesk Slov Oftalmol; 2022; 78(6):288-295. PubMed ID: 36543595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Q-switched neodymium YAG laser vitreolysis in the therapy of posterior segment disease.
    Jagger JD; Hamilton AM; Polkinghorne P
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(3):222-5. PubMed ID: 2361593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.